BRTX vs. PIMIX

In the year-to-date period, BRTX achieves a 22.73% return, which is significantly higher than PIMIX's 3.06% return. Over the past 10 years, BRTX has underperformed PIMIX with an annualized return of -62.69%, while PIMIX has yielded a comparatively higher 4.29% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for BioRestorative Therapies Inc (BRTX) and PIMCO Income Fund Institutional Class (PIMIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BRTX Sharpe Ratio is 0.47, which is lower than the PIMIX Sharpe Ratio of 1.93. The chart below compares the historical Sharpe Ratios of BRTX and PIMIX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

BRTX has not paid dividends to shareholders, while PIMIX's dividend yield for the trailing twelve months is around 6.21%.

The maximum BRTX drawdown since its inception was -100.00%, which is greater than PIMIX's maximum drawdown of -13.39%. Use the drawdown chart below to compare losses from any high point for BRTX and PIMIX.

BioRestorative Therapies Inc (BRTX) has a higher volatility of 15.16% compared to PIMCO Income Fund Institutional Class (PIMIX) at 1.32%. This indicates that BRTX's price experiences larger fluctuations and is considered to be riskier than PIMIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.